Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B S Ko

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Blood Cancer Journal|August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolutionH-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.
Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Blood Cancer Journal|August 1, 2015
TP53 mutations in de novo acute myeloid leukemia patients: longitudinal follow-ups show the mutation is stable during disease evolutionH-A Hou, W-C Chou, Y-Y Kuo, et al.
Leukemia|April 9, 2016
Genetic alterations and their clinical implications in older patients with acute myeloid leukemiaC-H Tsai, H-A Hou, J-L Tang, et al.
Blood Cancer Journal|January 21, 2014
Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndromeT-C Chen, H-A Hou, W-C Chou, et al.
Leukemia|August 10, 2013
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemiaH A Hou, C C Lin, W C Chou, et al.
Pageof 3